Prostate Cancer - Results from #26100

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer - Abstract April 4, 2012

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group - Abstract April 4, 2012

Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy - Abstract April 4, 2012

Association between smoking status, and free, total and percent free prostate specific antigen - Abstract April 4, 2012

Intensity modulated radiation therapy replaces 3-dimensional conformal radiotherapy as prostate cancer treatment - Abstract April 4, 2012

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study - Abstract April 4, 2012

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism - Abstract April 4, 2012

Active surveillance versus surgery for low risk prostate cancer: A clinical decision analysis - Abstract April 4, 2012

Management of prostate cancer biochemical recurrence in the clinical guidelines - Abstract April 4, 2012

Hormone therapy for prostate cancer April 4, 2012

Epidemiology April 3, 2012

Prostate Cancer Natural History April 3, 2012

Using manual prostate contours to enhance deformable registration of endorectal MRI - Abstract April 3, 2012

The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL - Abstract April 3, 2012

Dietary factors and epigenetic regulation for prostate cancer prevention - Abstract April 3, 2012

Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: An institutional report - Abstract April 3, 2012

Compassionate use of abiraterone and cabazitaxel : First experiences in docetaxel-pretreated castration-resistant prostate cancer patients - Abstract April 3, 2012

Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer - Abstract April 3, 2012

Quality of life after biochemical recurrence in patients with prostate cancer. How and how long do patients live after biochemical recurrence? - Abstract April 3, 2012

Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells - Abstract April 3, 2012

Page 1306 of 1437